1. Home
  2. CCRN vs SAGE Comparison

CCRN vs SAGE Comparison

Compare CCRN & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCRN
  • SAGE
  • Stock Information
  • Founded
  • CCRN 1986
  • SAGE 2010
  • Country
  • CCRN United States
  • SAGE United States
  • Employees
  • CCRN N/A
  • SAGE N/A
  • Industry
  • CCRN Professional Services
  • SAGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCRN Consumer Discretionary
  • SAGE Health Care
  • Exchange
  • CCRN Nasdaq
  • SAGE Nasdaq
  • Market Cap
  • CCRN 447.2M
  • SAGE 413.9M
  • IPO Year
  • CCRN N/A
  • SAGE 2014
  • Fundamental
  • Price
  • CCRN $13.18
  • SAGE $6.46
  • Analyst Decision
  • CCRN Hold
  • SAGE Hold
  • Analyst Count
  • CCRN 5
  • SAGE 19
  • Target Price
  • CCRN $17.93
  • SAGE $9.88
  • AVG Volume (30 Days)
  • CCRN 248.8K
  • SAGE 815.0K
  • Earning Date
  • CCRN 05-07-2025
  • SAGE 04-29-2025
  • Dividend Yield
  • CCRN N/A
  • SAGE N/A
  • EPS Growth
  • CCRN N/A
  • SAGE N/A
  • EPS
  • CCRN N/A
  • SAGE N/A
  • Revenue
  • CCRN $1,258,238,000.00
  • SAGE $47,404,000.00
  • Revenue This Year
  • CCRN N/A
  • SAGE $103.73
  • Revenue Next Year
  • CCRN $5.37
  • SAGE $41.15
  • P/E Ratio
  • CCRN N/A
  • SAGE N/A
  • Revenue Growth
  • CCRN N/A
  • SAGE N/A
  • 52 Week Low
  • CCRN $9.58
  • SAGE $4.62
  • 52 Week High
  • CCRN $18.50
  • SAGE $13.47
  • Technical
  • Relative Strength Index (RSI)
  • CCRN 23.59
  • SAGE 38.73
  • Support Level
  • CCRN $13.81
  • SAGE $6.36
  • Resistance Level
  • CCRN $13.96
  • SAGE $6.78
  • Average True Range (ATR)
  • CCRN 0.34
  • SAGE 0.24
  • MACD
  • CCRN -0.03
  • SAGE -0.01
  • Stochastic Oscillator
  • CCRN 2.41
  • SAGE 12.22

About CCRN Cross Country Healthcare Inc. $0.0001 Par Value

Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

Share on Social Networks: